MicroRNA and IncRNA in neurodegenerative diseases

Progress in Biochemistry and Biophysics

Volumn 37, Issue 8, 2010, Pages 826-833

  Huang, Wen Tao ^a   Guo, Xiang Qian ^b   Dai, Jia Pei ^a   Chen, Run Sheng ^b  

^a SOUTH CENTRAL UNIVERSITY FOR NATIONALITIES   (China)

^b INSTITUTE OF BIOPHYSICS   (China)

Author keywords

Long non coding rna; MicroRNA; Neurodegenerative diseases

Indexed keywords

EID: 78649242563     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1206.2010.00104     Document Type: Review

References (85)

1. Lander E S, Schork N J. Genetic dissection of complex traits. Science, 1994, 265(5181): 2037-2048
2. Birney E, Stamatoyannopoulos J A, Dutta A, et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature, 2007, 447(7146): 799-816
3. Wilusz J E, Sunwoo H, Spector D L. Long noncoding RNAs: functional surprises from the RNA world. Genes Dev, 2009, 23(13): 1494-1504
4. International Human Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome. Nature, 2004, 431(7011): 931-945
5. Clamp M, Fry B, Kamal M, et al. Distinguishing protein-coding and noncoding genes in the human genome. Proc Natl Acad Sci USA, 2007, 104(49): 19428-19433
6. Pruitt K D, Harrow J, Harte R A, et al. The consensus coding sequence (CCDS) project: Identifying a common protein-coding gene set for the human and mouse genomes. Genome Res, 2009, 19(7): 1316-1323
7. Qu L H. RNomics: The new frontier in the post-genomic era, Sci China C Life Sci, 2009, 52(3): 193-194
8. Prasanth K V, Spector D L. Eukaryotic regulatory RNAs: an answer to the 'genome complexity' conundrum. Genes Dev, 2007, 21(1): 11-42
9. Taft R J, Pheasant M, Mattick J S. The relationship between non-protein-coding DNA and eukaryotic complexity. Bioessays, 2007, 29(3): 288-299 (Pubitemid 46384167)
10. Mattick J S. The genetic signatures of noncoding RNAs. PLoS Genet, 2009, 5(4): e1000459
11. Griffiths-Jones S, Saini H K, van Dongen S, et al. miRBase: tools for microRNA genomics. Nucleic Acids Res, 2008, 36 (Database issue): D154-158
12. Jiang Q, Wang Y, Hao Y, et al. miR2Disease: a manually curated database for microRNA deregulation in human disease. Nucleic Acids Res, 2009, 37(Database issue): D98-104
13. Russo G, Giordano A. miRNAs: From biogenesis to networks. //Nikolsky Y, Bryant J. Methods in Molecular Biology: 563. Totowa NJ: Humana Press Inc., 2009.303-352
14. Vasudevan S, Tong Y, Steitz J A. Switching from repression to activation: microRNAs can up-regulate translation. Science, 2007, 318(5858): 1931-1934
15. Lewis B P, Burge C B, Bartel D P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell, 2005, 120(1): 15-20
16. Hebert S S, De Strooper B. Alterations of the microRNA network cause neurodegenerative disease. Trends Neurosci, 2009, 32 (4): 199-206
17. Sotiropoulou G, Pampalakis G, Lianidou E, et al. Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell. RNA, 2009, 15(8): 1443-1461
18. Bao L, Zhou M, Wu L, et al. PolymiRTS Database: linking polymorphisms in microRNA target sites with complex traits. Nucleic Acids Res, 2007, 35(Database issue): D51-54 (Pubitemid 46056169)
19. Lu M, Zhang Q, Deng M, et al. An analysis of human microRNA and disease associations. PLoS One, 2008, 3(10): e3420
20. Mercer T R, Dinger M E, Mattick J S. Long non-coding RNAs: insights into functions. Nat Rev Genet, 2009, 10(3): 155-159
21. Guttman M, Amit I, Garber M, et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature, 2009, 458(7235): 223-227
22. Khalil A M, Guttman M, Huarte M, et al. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci USA, 2009, 106(28): 11667-11672
23. Dinger M E, Pang K C, Mercer T R, et al. NRED: a database of long noncoding RNA expression. Nucleic Acids Res, 2009, 37(Database issue): D122-126
24. Ponting C P, Oliver P L, Reik W. Evolution and functions of long noncoding RNAs. Cell, 2009, 136(4): 629-641
25. Huang S J, Zhu D H. Sci China C Life Sci, 2009, 39(1) 21-30
26. Lee J T, Davidow L S, Warshawsky D. Tsix, a gene antisense to Xist at the X-inactivation centre. Nat Genet, 1999, 21(4): 400-404 (Pubitemid 29159577)
27. Kalantry S, Purushothaman S, Bowen R B, et al. Evidence of Xist RNA-independent initiation of mouse imprinted X-chromosome inactivation. Nature, 2009, 460(7255): 647-651
28. Matouk I J, DeGroot N, Mezan S, et al. The H19 non-coding RNA is essential for human tumor growth. PLoS One, 2007, 2(9): e845 (Pubitemid 351420364)
29. Yoshimizu T, Miroglio A, Ripoche M A, et al. The H19 locus acts in vivo as a tumor suppressor. Proc Natl Acad Sci USA, 2008, 105(34): 12417-12422
30. Sotomaru Y, Katsuzawa Y, Hatada I, et al. Unregulated expression of the imprinted genes H19 and Igf2r in mouse uniparental fetuses. J Biol Chem, 2002, 277(14): 12474-12478 (Pubitemid 34952822)
31. Redrup L, Branco M R, Perdeaux E R, et al. The long noncoding RNA Kcnq1ot1 organises a lineage-specific nuclear domain for epigenetic gene silencing. Development, 2009, 136(4): 525-530
32. Rinn J L, Kertesz M, Wang J K, et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell, 2007, 129(7): 1311-1323 (Pubitemid 46962090)
33. Ponjavic J, Ponting C P, Lunter G. Functionality or transcriptional noise? Evidence for selection within long noncoding RNAs. Genome Res, 2007, 17(5): 556-565 (Pubitemid 46715505)
34. Croce C M. Oncogenes and cancer. N Engl J Med, 2008, 358(5): 502-511
35. Esquela-Kerscher A, Slack F J. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer, 2006, 6(4): 259-269
36. Lukiw W J. Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus. Neuroreport 2007, 18(3): 297-300 (Pubitemid 46303785)
37. Sethi P, Lukiw W J. Micro-RNA abundance and stability in human brain: specific alterations in Alzheimer's disease temporal lobe neocortex. Neurosci Lett, 2009, 459(2): 100-104
38. Boissonneault V, Plante I, Rivest S, et al. MicroRNA-298 and microRNA-328 regulate expression of mouse beta-amyloid precursor protein-converting enzyme 1. J Biol Chem, 2009, 284(4): 1971-1981
39. Wang W X, Rajeev B W, Stromberg A J, et al. The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J Neurosci, 2008, 28(5): 1213-1223
40. Hebert S S, Horre K, Nicolai L, et al. Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACEl/beta-secretase expression. Proc Natl Acad Sci USA, 2008, 105(17): 6415-6420 (Pubitemid 351758360)
41. Shioya M, Obayashi S, Tabunoki H, et al. Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neuron navigator-3. Neuropathol Appl Neurobiol, 2010, 36(4): 320-330
42. Hebert S S, Horre K, Nicolai L, et al. MicroRNA regulation of Alzheimer's Amyloid precursor protein expression. Neurobiol Dis, 2009, 33(3): 422-428
43. Rademakers R, Eriksen J L, Baker M, et al. Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia. Hum Mol Genet, 2008, 17(23): 3631-3642
44. Bettens K, Brouwers N, Engelborghs S, et al. APP and BACE1 miRNA genetic variability has no major role in risk for Alzheimer disease. Hum Mutat, 2009, 30(8): 1207-1213
45. Lesage S, Brice A. Parkinson's disease: from monogenic forms to genetic susceptibility factors. Hum Mol Genet, 2009,18(R1): R48-59
46. Kim J, Inoue K, Ishii J, et al. A MicroRNA feedback circuit in midbrain dopamine neurons. Science, 2007, 317(5842): 1220-1224
47. Hebert S S, De Strooper B. Molecular biology. miRNAs in neurodegeneration. Science, 2007, 317(5842): 1179-1180
48. Wang G, van der Walt J M, Mayhew G, et al. Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein. Am J Hum Genet, 2008, 82(2): 283-289
49. Gil J M, Rego A C. Mechanisms of neurodegeneration in Huntington's disease. Eur J Neurosci, 2008, 27(11): 2803-2820
50. Ross C A. Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington's disease and related disorders. Neuron, 2002, 35(5): 819-822
51. Bilen J, Liu N, Burnett B G, et al. MicroRNA pathways modulate polyglutamine-induced neurodegeneration. Mol Cell, 2006, 24(1): 157-163 (Pubitemid 44466675)
52. Lee Y, Samaco R C, Gatchel J R, et al. miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis. Nat Neurosci, 2008, 11(10): 1137-1139
53. Conaco C, Otto S, Han J J, et al. Reciprocal actions of REST and a microRNA promote neuronal identity. Proc Natl Acad Sci USA, 2006, 103(7): 2422-2427
54. Johnson R, Zuccato C, Belyaev N D, et al. A microRNA-based gene dysregulation pathway in Huntington's disease. Neurobiol Dis, 2008, 29(3): 438-445
55. Packer A N, Xing Y, Harper S Q, et al. The bifunctional microRNA miR-9/miR-9* regulates REST and CoREST and is downregulated in Huntington's disease. J Neurosci, 2008, 28(53): 14341-14346
56. Savas J N, Makusky A, Ottosen S, et al. Huntington's disease protein contributes to RNA-mediated gene silencing through association with Argonaute and P bodies. Proc Natl Acad Sci USA, 2008, 105(31): 10820-10825
57. Costa F F. Non-coding RNAs: new players in eukaryotic biology. Gene, 2005, 357(2): 83-94
58. Szymanski M, Barciszewska M Z, Erdmann V A, et al. A new frontier for molecular medicine: noncoding RNAs. Biochim Biophys Acta, 2005, 1756(1): 65-75
59. Hao Y, Crenshaw T, Moulton T, et al. Tumour-suppressor activity of H19 RNA. Nature, 1993, 365(6448): 764-767
60. Brannan C I, Dees E C, Ingram R S, et al. The product of the H19 gene may function as an RNA. Mol Cell Biol, 1990, 10(1): 28-36
61. Broadbent H M, Peden J F, Lorkowski S, et al. Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p. Hum Mol Genet, 2008, 17(6): 806-814
62. Srikantan V, Zou Z, Petrovics G, et al. PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer. Proc Natl Acad Sci USA, 2000, 97(22): 12216-12221
63. Zhou Y, Zhong Y, Wang Y, et al. Activation of p53 by MEG3 non-coding RNA. J Biol Chem, 2007, 282(34): 24731-24742 (Pubitemid 47347547)
64. Yu W, Gius D, Onyango P, et al. Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. Nature, 2008, 451(7175): 202-206
65. Gupta R A, Shah N, Wang K C, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature, 464(7291): 1071-1076
66. de Kok J B, Verhaegh G W, Roelofs R W, et al. DD3(PCA3), a very sensitive and specific marker to detect prostate tumors. Cancer Res, 2002, 62(9): 2695-2698
67. Lin R, Maeda S, Liu C, et al. A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas. Oncogene, 2007, 26(6): 851-858
68. Szell M, Bata-Csorgo Z, Kemeny L. The enigmatic world of mRNA-like ncRNAs: their role in human evolution and in human diseases. Semin Cancer Biol, 2008, 18(2): 141-148
69. Xie W, Ted Brown W, Denman R B. Translational regulation by non-protein-coding RNAs: different targets, common themes. Biochem Biophys Res Commun, 2008, 373(4): 462-466
70. Lukiw W J, Handley P, Wong L, et al. BC200 RNA in normal human neocortex, non-Alzheimer dementia (NAD), and senile dementia of the Alzheimer type (AD). Neurochem Res, 1992, 17(6): 591-597
71. Mus E, Hof P R, Tiedge H. Dendritic BC200 RNA in aging and in Alzheimer's disease. Proc Natl Acad Sci USA, 2007, 104(25): 10679-10684 (Pubitemid 47185724)
72. Dieci G, Fiorino G, Castelnuovo M, et al. The expanding RNA polymerase III transcriptome. Trends Genet, 2007, 23(12): 614-622 (Pubitemid 350180140)
73. Faghihi M A, Modarresi F, Khalil A M, et al. Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Nat Med, 2008, 14(7): 723-730
74. Johnson J M, Edwards S, Shoemaker D, et al. Dark matter in the genome: evidence of widespread transcription detected by microarray tiling experiments. Trends Genet, 2005, 21(2): 93-102
75. Nelson P T, Keller J N. RNA in brain disease: no longer just "the messenger in the middle". J Neuropathol Exp Neurol, 2007, 66(6): 461-468
76. Nilsen T W. Endo-siRNAs: yet another layer of complexity in RNA silencing. Nat Struct Mol Biol, 2008, 15(6): 546-548
77. Taft R J, Glazov E A, Cloonan N, et al. Tiny RNAs associated with transcription start sites in animals. Nat Genet, 2009, 41 (5): 572-578
78. Lee H C, Chang S S, Choudhary S, et al. qiRNA is a new type of small interfering RNA induced by DNA damage. Nature, 2009, 459(7244): 274-277
79. Wang J, Liu X, Wu H, et al. CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer [J/OL]. Nucleic Acids Res 2010-04-27. http://nar.oxfordjoumals.org/cgi/content/abstract/ gkq285v1
80. Farrall M, Morris A P. Gearing up for genome-wide gene-association studies. Hum Mol Genet, 2005, 14(2): R157-162
81. Huang W T, Dai J P, Chen R S. J South-Central University for Nationalities(Nat. Sei. Edition), 2009, 28(3): 47-57
82. Visscher P M, Montgomery G W. Genome-wide association studies and human disease: from trickle to flood. JAMA, 2009, 302(18): 2028-2029
83. Sethupathy P, Collins F S. MicroRNA target site polymorphisms and human disease. Trends Genet, 2008, 24(10): 489-497
84. Meola N, Gennarino V A, Banfi S. microRNAs and genetic diseases. Pathogenetics, 2009, 2(1): 7
85. Kretzschmar H. Brain banking: opportunities, challenges and meaning for the future. Nat Rev Neurosci, 2009, 10(1): 70-78